We soon could find ourselves dealing with a whole new kind of lost generation. One that’s made up of the very workers your organization will presumably need to dig out.
Racial, ethnic disparities seen in mAb treatment for COVID-19
Jan 19, 2022
Monoclonal antibody treatment was used infrequently among all racial, ethnic groups; Hispanics received mAbs less often than non-Hispanics.
16.8 million undiagnosed COVID-19 cases in first six months in U.S.
Jun 30, 2021
The overall weighted undiagnosed seropositivity estimate was 4.6%, with estimates ranging from 1.1 to 14.2% by subgroup.
Vaccine effectiveness against SARS-CoV-2 infection wanes over time
Jun 14, 2022
However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.
SARS-CoV-2-linked hospitalization, ED encounters rare after Paxlovid
Jun 28, 2022
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had a hospitalization or emergency department encounter.
Help for home health? Due date approaching for repayment of COVID-19 loans
By
Diane Eastabrook
Mar 23, 2021
Some home healthcare providers soon may be in for a rude awakening. Bills for Medicare Accelerated and Advanced Payments to the federal government come due in a few weeks.
Loan application deadline extended for Paycheck Protection Program
By
John O'Connor
Jul 07, 2020
Smaller senior living operators may still apply for a Paycheck Protection Program loan of up to $10 million, thanks to a law extension.
CDC: Monitoring of COVID-19 will remain a priority
May 08, 2023
Surveillance of COVID-19 and COVID-19-associated mortality after expiration of the COVID-19 public health emergency declaration on May 11 will continue.
To help those who are considering or are currently rolling out a vaccine requirement for staff, here are some lessons from our rollout that may be useful.
~30 percent of seniors have sequelae after acute SARS-CoV-2
Feb 10, 2022
The greatest excess risk was seen for respiratory failure, fatigue, hypertension and memory difficulties compared with matched individuals without COVID-19.